Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study on the Potential of Circulating Tumor DNA to Assess the Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

NCT03688035 is registered in ClinicalTrials.gov with Zhiyong Yu as lead sponsor.

NCT NCT03688035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03688035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study on the Potential of Circulating Tumor DNA to Assess the Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
Lead sponsor
Zhiyong Yu
Phase
Observational
Overall status
Unknown status
Start date
September 20, 2018
Completion date
September 20, 2019
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, circulating tumor dna, neoadjuvant chemotherapy